Stocks and Investing Stocks and Investing
Thu, August 15, 2024

Christopher Raymond Initiated (TYRA) at Buy and Held Target at $33 on, Aug 15th, 2024


Published on 2024-10-28 13:40:47 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Initiated "Tyra Biosciences, Inc." (TYRA) at Buy and Held Target at $33 on, Aug 15th, 2024.

Christopher has made no other calls on TYRA in the last 4 months.



There are 3 other peers that have a rating on TYRA. Out of the 3 peers that are also analyzing TYRA, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Christopher


  • Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $25 on, Thursday, August 8th, 2024
  • Robert Driscoll of "Wedbush" Reiterated at Buy and Held Target at $28 on, Thursday, August 8th, 2024
  • Mitchell Kapoor of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $23 on, Wednesday, July 3rd, 2024

Contributing Sources